Article
Digitoxin promotes apoptosis and inhibits proliferation and migration by reducing HIF-1α and STAT3 in KRAS mutant human colon cancer cells.
Chemico-biological interactions - 5 Jan 2022
Mi Chunliu, Cao Xiangxiang, Ma Kai, Wei Mian, Xu Wenjing, Lin Yan, Zhang Jihong, Wang Tian-Yun
Abstract excerpt
Colon cancer patients with mutant KRAS are resistant to cetuximab, an antibody directed against the epidermal growth factor receptor. New treatment options are needed to improve survival in patients with KRAS mutated colorectal cancer. Digitoxin is a cardiotonic drug, which has been demonstrated to exhibit anticancer effects in a number of cancers. However, the anticancer mechanisms of digitoxin in KRAS mutant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
